Innovation Global
San Francisco, California, United StatesFounded 2013
Innovation Global Capital is a San Francisco-based venture capital firm founded in 2013 that builds disruptive early-stage companies transforming industries through AI, advanced technology, and innovation.
Average disclosed round size is $29.8M (across 49 rounds with reported amounts).
Portfolio
47
Fund Size
—
Top Stage
Series A
Last 12 Mo
0
Team
YK
Yasunobu Kyogoku
Founding Partner
MZ
Mo Z.
Founder
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
60 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| CCulturePulse | Series A | — | Mar 2025 |
 RegCell | Seed | $8.5M | Mar 2025 |
 Cornerstone Robotics | Series C | $70M | Jan 2025 |
 Cornerstone Robotics | Series C | $200M | Jan 2025 |
 Fyteko | Series B | — | Jan 2025 |
 Keey Aerogel | Series A | — | Jan 2025 |
 Monarch | Seed | $4.8M | Jan 2025 |
 Dioseve | Unknown | $7M | Jan 2024 |
 Syntegra | Seed | — | Jan 2022 |
 Aloxy | Growth | — | Jan 2022 |
| TTimeseer | Seed | $6M | Jan 2022 |
| SSwanBio Therapeutics | Series B | $133M | Jan 2022 |
 Cognigy | Series B | $44M | Jun 2021 |
 REIN4CED | Series B | — | Apr 2021 |
| REIN4CED | Series B | — | Jan 2021 |
| AAffinia Therapeutics | Series C | $40M | Mar 2020 |
 Affinia | Series A | $60M | Mar 2020 |
| AAffinia Therapeutics | Series A | $60M | Mar 2020 |
 Keros Therapeutics | Series C | $56M | Mar 2020 |
| AAkouos | Series B | — | Mar 2020 |
| AAffinia Therapeutics | Series A | $60M | Jan 2020 |
| Affinia | Series A | $60M | Jan 2020 |
| NNocion | Series A | $27M | Jan 2019 |
 Nocion Therapeutics | Series A | $27M | Jan 2019 |
| AAkouos | Series A | $50M | Aug 2018 |
Page 1 of 3
Top Co-Investors
Atlas Venture14 shared
GV10 shared
New Enterprise Associates8 shared
F-Prime Capital7 shared
Alexandria Venture Investments6 shared
Mass General Brigham Ventures5 shared
Alphabet Inc.4 shared
Tau Ventures4 shared
Gaingels4 shared
Grep VC4 shared
NextGen Venture Partners4 shared
SR One3 shared
The Kraft Group3 shared
Cowen Healthcare Investments3 shared
Launchpad Capital3 shared
Novartis Venture Fund3 shared
Access Industries2 shared
Pontifax2 shared
Arkin Bio Ventures2 shared
Forerunner Ventures2 shared
Last updated: 20 October 2026